This audio article is from VisualFieldTest.com.

Read the full article here: https://visualfieldtest.com/en/molecular-hydrogen-and-redox-signaling-in-ocular-neuroprotection

Test your visual field online: https://visualfieldtest.com

Excerpt:

Introduction Eye diseases like glaucoma, diabetic retinopathy and age-related macular degeneration share a common culprit: oxidative stress from harmful reactive oxygen species (ROS). Excess ROS can damage DNA, lipids and proteins in the retina and optic nerve, driving vision loss () (). Molecular hydrogen (H₂) has emerged as a unique antioxidant therapy. H₂ is a tiny, tasteless gas that easily penetrates cell membranes and ocular barriers (). It selectively neutralizes only the most toxic ROS (like hydroxyl radicals •OH and peroxynitrite ONOO⁻) while leaving normal signaling ROS intact (). In doing so, H₂ restores cellular redox balance without blocking beneficial biochemical signals. In addition, H₂ can trigger protective pathways – for example, it upregulates antioxidant enzymes (superoxide dismutase, catalase, glutathione systems) via Nrf2 signaling and suppresses pro-inflammatory factors () (). These properties suggest H₂ could guard retinal neurons (and the optic nerve) by modulating redox signaling in ophthalmic tissues. Mechanisms of H₂ Action in Ocular Tissues The therapeutic appeal of H₂ lies in its physical properties. As the smallest molecule, it diffuses rapidly through tissues and bio-barriers (). For example, inhaled H₂ or hydrogen-saturated water (HRW) quickly elevates H₂ levels in the blood and eyes. Once inside cells, H₂ “soaks up” highly reactive radicals. Unlike general antioxidants, H₂ does not indiscriminately scavenge all ROS – it reacts preferentially with the strongest oxidants (). This means normal ROS signaling (needed for cell function) is preserved while damaging radicals are detoxified. In practice, studies show H₂ lowers oxidative biomarkers (like 4-hydroxynonenal and malondialdehyde) and inflammatory mediators in ocular cells and tissues. Importantly, H₂ also modulates signaling pathways. It has been shown to activate the master antioxidant regulator Nrf2 (boosting cellular defenses) and inhibit inflammatory cascades (for example suppressing NF-κB and pro-inflammatory cytokines) () (). In the eye, this translates to reduced microglial activation and cell death after injury () (). In short, H₂ acts as a gentle, “tunable” antioxidant that changes the redox environment and gene expression in a protective direction. Experimental Ocular Neuroprotection A growing body of animal research supports H₂’s neuroprotective role in the eye. In rodent glaucoma models (e.g. acute intraocular pressure spikes), H₂ treatment consistently preserved retinal neurons. For instance, one study gave rats continuous H₂-enriched eye drops during pressure-induced ischemia, and found the vitreous H₂ level rose quickly. This intervention suppressed I/R-induced oxidative stress and sharply reduced retinal ganglion cell (RGC) apoptosis (). Similarly, intraperitoneal injection of hydrogen-rich saline (HRS) in rats limited retinal DNA oxidation and blunted over-activation of PARP-1 (a DNA repair enzyme that can trigger cell death). As a result, fewer RGCs died after injury (). In another experiment, inhaling H₂ gas for one hour daily (7 days) significantly lessened RGC loss in a rat retinal ischemia-reperfusion model (). Notably, measured inflammatory mediators (IL-1β, TNF-α) and oxidative byproducts (4-HNE) were much lower in H₂-treated eyes (). These findings highlight that H₂ can mitigate the oxidative and inflammatory cascades underlying glaucomatous n

Support the show